Skip to content
Storytelling Co – Lifestyle
Author:
Tarsus Pharmaceuticals, Inc
Tarsus Plans to Present 11 Abstracts Highlighting New Insights in Demodex Blepharitis, Ocular Rosacea and the Real-World Impact of XDEMVY at the American Academy of Optometry 2026 Annual Meeting
September 29, 2026
Tarsus Pharmaceuticals Completes Acquisition of Alkeus Pharmaceuticals, Expanding Leadership in Eye Care
September 4, 2026
Tarsus to Participate in Upcoming Investor Conferences
September 1, 2026
Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals and Advance Eye Care Leadership Position
August 6, 2026
Tarsus Pharmaceuticals Announces Oversubscribed $125.0 Million Private Placement Equity Financing
August 6, 2026
Tarsus Reports Second Quarter 2026 Financial Results, Advances Next Phase of Growth
August 6, 2026
Tarsus to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026
August 5, 2026
Tarsus Pharmaceuticals Announces Executive Leadership Transition as Company Advances Next Phase of Growth
July 13, 2026
Tarsus Advances Eye Care Leadership Strategy with Acquisition of iRenix Medical and Late-Stage Asset IRX-101
July 8, 2026
Tarsus to Participate in Upcoming Investor Conferences
May 28, 2026
1
2
Next Page
→